Source:http://linkedlifedata.com/resource/pubmed/id/19375342
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7-8 Suppl
|
pubmed:dateCreated |
2009-6-16
|
pubmed:abstractText |
As part of phase I/II melanoma BNCT clinical trial conducted in Argentina in a cooperative effort of the Argentine Atomic Energy Commission (CNEA) and the Oncology Institute Angel H. Roffo (IOAHR), 7 patients (6 female-1 male) received eight treatment sessions covering ten anatomical areas located in extremities. Mean age of the patients was 64 years (51-74). The treatments were performed between October 2003 and June 2007. All patients presented multiple subcutaneous skin metastases of melanoma and received an infusion containing approximately 14 gr/m(2) of (10)borophenyl-alanine (BPA) followed by the exposition of the area to a mixed thermal-epithermal neutron beam at the RA-6 reactor. The maximum prescribed dose to normal skin ranged from 16.5 to 24 Gy-Eq and normal tissue administered dose varied from 15.8 to 27.5 Gy-Eq. Considering evaluable nodules, 69.3% of overall response and 30.7% of no changes were seen. The toxicity was acceptable, with 3 out of 10 evaluable areas showing ulceration (30% toxicity grade 3).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1872-9800
|
pubmed:author |
pubmed-author:BlaumannHH,
pubmed-author:Calzetta LarrieuO AOA,
pubmed-author:CasalM RMR,
pubmed-author:FalkH CHC,
pubmed-author:FernándezCC,
pubmed-author:GonzálezS JSJ,
pubmed-author:Jiménez RebagliatiRR,
pubmed-author:KesslerJJ,
pubmed-author:LibermanS JSJ,
pubmed-author:LonghiniLL,
pubmed-author:MarboeChuckC,
pubmed-author:MenéndezP RPR,
pubmed-author:PereiraM DMD,
pubmed-author:RothB M CBM,
pubmed-author:Santa CruzG AGA
|
pubmed:issnType |
Electronic
|
pubmed:volume |
67
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S50-3
|
pubmed:meshHeading |
pubmed-meshheading:19375342-Aged,
pubmed-meshheading:19375342-Argentina,
pubmed-meshheading:19375342-Boron Compounds,
pubmed-meshheading:19375342-Boron Neutron Capture Therapy,
pubmed-meshheading:19375342-Female,
pubmed-meshheading:19375342-Humans,
pubmed-meshheading:19375342-Leg,
pubmed-meshheading:19375342-Male,
pubmed-meshheading:19375342-Melanoma,
pubmed-meshheading:19375342-Middle Aged,
pubmed-meshheading:19375342-Phenylalanine,
pubmed-meshheading:19375342-Radiation-Sensitizing Agents,
pubmed-meshheading:19375342-Radiotherapy Dosage,
pubmed-meshheading:19375342-Radiotherapy Planning, Computer-Assisted,
pubmed-meshheading:19375342-Skin Neoplasms
|
pubmed:year |
2009
|
pubmed:articleTitle |
BNCT for skin melanoma in extremities: updated Argentine clinical results.
|
pubmed:affiliation |
Instituto de Oncología Angel H. Roffo. Av. San Martín 5481, (1417) Cdad. de Buenos Aires, Argentina. pmenende@yahoo.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II,
Clinical Trial, Phase I
|